| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Kevin Laupland | Q87139465 |
| P2093 | author name string | John M Conly | |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Staphylococcus aureus | Q188121 |
| mupirocin | Q413578 | ||
| P304 | page(s) | 933-938 | |
| P577 | publication date | 2003-09-08 | |
| P1433 | published in | Clinical Infectious Diseases | Q5133764 |
| P1476 | title | Treatment of Staphylococcus aureus colonization and prophylaxis for infection with topical intranasal mupirocin: an evidence-based review | |
| P478 | volume | 37 |
| Q37405328 | A Double-Blind, Randomized, Controlled Trial of Topical Polysporin Triple Compound Versus Topical Mupirocin for the Eradication of Colonization with Methicillin-ResistantStaphylococcus aureusin a Complex Continuing Care Population |
| Q37363367 | A simple prophylaxis regimen for MRSA: its impact on the incidence of infection in patients undergoing liver resection |
| Q49605790 | Antibiotic Resistance Trends in Methicillin-Resistant Staphylococcus aureus Isolated in Kuwait Hospitals: 2011-2015. |
| Q38010519 | Antibiotic overuse and resistance in dermatology |
| Q37140319 | Association between Staphylococcus aureus nasal carriage and disease phenotype in patients affected by systemic lupus erythematosus |
| Q40173751 | Bacterial Infections in Neonates Following Mupirocin-Based MRSA Decolonization: A Multicenter Cohort Study |
| Q51112120 | Budget impact analysis of rapid screening for Staphylococcus aureus colonization among patients undergoing elective surgery in US hospitals . |
| Q35822053 | Clinical Effectiveness of Mupirocin for Preventing Staphylococcus aureus Infections in Nonsurgical Settings: A Meta-analysis. |
| Q34157657 | Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children |
| Q38811339 | Colonization With Methicillin-resistant Staphylococcus aureus and Risk for Infection Among Asymptomatic Athletes: A Systematic Review and Metaanalysis |
| Q40115963 | Combining Two Methods of Global Sensitivity Analysis to Investigate MRSA Nasal Carriage Model |
| Q36108084 | Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat |
| Q28395537 | Community-associated methicillin-resistant Staphylococcus aureus skin infections in a religious community |
| Q39486100 | Comparison of the BBL CHROMagar Staph aureus agar medium to conventional media for detection of Staphylococcus aureus in respiratory samples |
| Q28300379 | Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus |
| Q36474366 | Consensus guidelines for the prevention and treatment of catheter-related infections and peritonitis in pediatric patients receiving peritoneal dialysis: 2012 update. |
| Q46938132 | Does nasal colonization or mupirocin treatment affect recurrence of methicillin-resistant Staphylococcus aureus skin and skin structure infections? |
| Q36482018 | Effectiveness of measures to eradicate Staphylococcus aureus carriage in patients with community-associated skin and soft-tissue infections: a randomized trial |
| Q80990734 | Eradicating Nasal Carriage of Staphylococcus aureus As a Strategy for Preventing Health Care-associated Infections in Nonsurgical Patients |
| Q41813480 | In vitro and in vivo evaluations of the activities of lauric acid monoester formulations against Staphylococcus aureus |
| Q41694534 | Incidence and Risk Factors of Nasal Carriage of Staphylococcus aureus in HIV-Infected Individuals in Comparison to HIV-Uninfected Individuals: A Case-Control Study |
| Q37971165 | Infections in vascular surgery |
| Q24240902 | Interventions for preventing infectious complications in haemodialysis patients with central venous catheters |
| Q42009908 | Investigation of the potential for mutational resistance to XF-73, retapamulin, mupirocin, fusidic acid, daptomycin, and vancomycin in methicillin-resistant Staphylococcus aureus isolates during a 55-passage study |
| Q51060261 | Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: position statement from the Joint SHEA and APIC Task Force. |
| Q40108345 | Methicillin-resistant Staphylococcus aureus: from the hospital to the community |
| Q42565043 | Mode of action and biochemical characterization of REP8839, a novel inhibitor of methionyl-tRNA synthetase |
| Q46643844 | Mupirocin for controlling methicillin-resistant Staphylococcus aureus: lessons from a decade of use at a university hospital |
| Q24241136 | Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers |
| Q34546013 | Mupirocin resistance in nasal carriage of Staphylococcus aureus among healthcare workers of a tertiary care rural hospital |
| Q34497215 | Nasal carriage of methicillin-resistant Staphylococcus aureus is associated with higher all-cause mortality in hemodialysis patients |
| Q33984713 | National athletic trainers' association position statement: skin diseases |
| Q43172109 | Nosocomial infections in neonatal intensive care units: profile, risk factor assessment and antibiogram |
| Q36370327 | Perioperative intranasal mupirocin for the prevention of surgical-site infections: systematic review of the literature and meta-analysis |
| Q35999513 | Perioperative pharmacotherapy in patients with left ventricular assist devices |
| Q36676194 | Preoperative use of mupirocin for the prevention of healthcare-associated Staphylococcus aureus infections: a cost-effectiveness analysis |
| Q36005464 | Prevention of Recurrent Staphylococcal Skin Infections |
| Q35873014 | Recurring methicillin-resistant Staphylococcus aureus infections in a football team |
| Q34585413 | Retapamulin: a semisynthetic pleuromutilin compound for topical treatment of skin infections in adults and children |
| Q37960575 | Staphylococcal decolonisation: an effective strategy for prevention of infection? |
| Q40697398 | Staphylococcus aureus: the current state of disease, pathophysiology and strategies for prevention |
| Q33999091 | Successful control of methicillin-resistant Staphylococcus aureus in endemic neonatal intensive care units--a 7-year campaign |
| Q36095019 | Targeted intranasal mupirocin to prevent colonization and infection by community-associated methicillin-resistant Staphylococcus aureus strains in soldiers: a cluster randomized controlled trial |
| Q41194288 | Targeting Multiple Aminoacyl-tRNA Synthetases Overcomes the Resistance Liabilities Associated with Antibacterial Inhibitors Acting on a Single Such Enzyme |
| Q34283504 | The NOSE Study (Nasal Ointment for Staphylococcus aureus Eradication): A Randomized Controlled Trial of Monthly Mupirocin in HIV-Infected Individuals |
| Q37340558 | Treatment and recurrence management of staphylococcal infections: community-acquired MRSA. |
| Q37322249 | Treatment strategies for methicillin-resistant Staphylococcus aureus infections in pediatrics |
| Q24811715 | Use of intranasal mupirocin to prevent methicillin-resistant Staphylococcus aureus infection in intensive care units |
| Q39876599 | Use of mupirocin-chlorhexidine treatment to prevent Staphylococcus aureus surgical-site infections |
| Q39513183 | Variability in infection control measures for the percutaneous lead among programs implanting long-term ventricular assist devices in the United States |
| Q48372824 | Ventilator-associated pneumonia in severe traumatic brain injury |
| Q28247483 | Ventricular assist device-related infections |
| Q83989074 | [Current perioperative antibiotic prophylaxis] |
Search more.